NovoCure
NVCR
NVCR
63 hedge funds and large institutions have $161M invested in NovoCure in 2016 Q3 according to their latest regulatory filings, with 9 funds opening new positions, 26 increasing their positions, 13 reducing their positions, and 11 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more funds holding in top 10
Funds holding in top 10: →
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less funds holding
Funds holding: →
18% less first-time investments, than exits
New positions opened: 9 | Existing positions closed: 11
30% less capital invested
Capital invested by funds: $228M → $161M (-$67.7M)
Holders
63
Holding in Top 10
2
Calls
$2.43M
Puts
$470K
Top Buyers
| 1 | +$6.56M | |
| 2 | +$4.27M | |
| 3 | +$2.17M | |
| 4 |
ACM
Asymmetry Capital Management
San Francisco,
California
|
+$1.34M |
| 5 |
BFA
BlackRock Fund Advisors
San Francisco,
California
|
+$717K |
Top Sellers
| 1 | -$30.1M | |
| 2 | -$6.66M | |
| 3 | -$1,000K | |
| 4 |
ARTA
A.R.T. Advisors
New York
|
-$694K |
| 5 |
Macquarie Group
Sydney, NSW 2000,
Australia
|
-$585K |